Concepedia

Marc C. Chamberlain

MC

191

Publications

17.7K

Citations

69

H-Index

1987

Active since

Affiliations

University of Washington(Current)

Fred Hutch Cancer Center

University of California San Diego

Neurological Surgery

Seattle Cancer Care Alliance

Marc C. Chamberlain is an author at University of Washington specializing in medicine, neuro-oncology, and oncology.

ORCID

Top concepts

Publications per year

1987–2025

191

Publications

191

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

Patrick Y. Wen, David R. Macdonald, David A. Reardon et al. · Journal of Clinical Oncology · 2010 · 3.7K citations · Full text

, , +23

A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.

Michael Glantz, Kurt A. Jaeckle, Marc C. Chamberlain et al. · PubMed · 1999 · 526 citations

, , +13

Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma

Wolfgang Wick, Vinay K. Puduvalli, Marc C. Chamberlain et al. · Journal of Clinical Oncology · 2010 · 507 citations

Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous Meningitis

Michael Glantz, Suzanne LaFollette, Kurt A. Jaeckle et al. · Journal of Clinical Oncology · 1999 · 398 citations

Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma

Marc C. Chamberlain, Michael Glantz, Lisa Chalmers et al. · Journal of Neuro-Oncology · 2006 · 339 citations

, , +7

Rows per page

1–5 of 191